title: Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
abstract: BACKGROUND
  Hypertension, hypercholesterolemia, and diabetes are the main causes of cardiovascular diseases in developed countries. However, these conditions are still poorly recognized and treated.
  
  
  OBJECTIVE
  This study aimed at estimating the prevalence, awareness, treatment, and control rates of major cardiovascular risk factors in an unselected sample of individuals of a small community located in northern Italy.
  
  
  METHODS
  We screened 344 sequential subjects in this study. Data collection included family and clinical history, anthropometric data, blood pressure, blood glucose, and serum cholesterol values. Individual cardiovascular risk profiles were assessed by risk charts of the Progetto Cuore.
  
  
  RESULTS
  Based on personal history and/or measured values, 78.2% of subjects had hypercholesterolemia (total cholesterol levels > 190 mg/dL), 61.0% had central obesity (waist circumference ≥ 94 cm for men and ≥80 cm for women), 51.2% had arterial hypertension (blood pressure ≥ 140/90 mmHg), 8.1% had diabetes (blood glucose ≥ 126 mg/dL), 22.7% had impaired fasting glucose (blood glucose 100-125 mg/dL), and 35.5% were overweight (body mass index 25-29 kg/m(2)). Alcohol drinkers and smokers accounted for 46.2% and 22.4% of subjects, respectively. Awareness of hypertension, hypercholesterolemia, and diabetes was poor, and control of these risk factors, except for diabetes, was even worse. Prevalence of high blood pressure, high serum cholesterol, overweight, and obesity significantly increased with aging. Hypercholesterolemia and obesity were significantly more common in women, while overweight and diabetes in men. In 15.4% of participants, the risk of a major cardiovascular event in the next 10 years was either high or very high.
  
  
  CONCLUSIONS
  In a small community in a wealthy region of Italy, the prevalence of major cardiovascular risk factors is high, while awareness, treatment, and control are poor. Such a result highlights the importance of screening campaigns as a strategy to improve early diagnosis and access to treatment, and thus effective prevention of cardiovascular diseases in the general population.
authors: Italian Institute of Telemedicine and Association for Research and Development of Biomedical Technologies and for Continuing Medical Education (ARSMED), Varese, Italy. stefano.omboni@iitelemed.org
authors: Stefano
authors: S
authors: Omboni
authors: Giorgia
authors: G
authors: Carabelli
authors: Edoardo
authors: E
authors: Ghirardi
authors: Stefano
authors: S
authors: Carugo
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001364:Awareness; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D016009:Chi-Square Distribution; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D042241:Early Diagnosis; D005260:Female; D015438:Health Behavior; D007722:Health Knowledge, Attitudes, Practice; D006293:Health Promotion; D006801:Humans; D006937:Hypercholesterolemia / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D006973:Hypertension / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007558:Italy / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D011237:Predictive Value of Tests; D015995:Prevalence; D011314:Preventive Health Services / Q000379:methods; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D055815:Young Adult
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents
keywords: Italy; cardiovascular risk; diabetes; hypercholesterolemia; hypertension; obesity
references: Circulation. 2001 Dec 4;104(23):2855-64
references: 11733407
references: J Int Fed Clin Chem. 1991 Sep;3(4):154-9
references: 10149817
references: Lancet. 2005 Sep 24-30;366(9491):1059-62
references: 16182882
references: Circulation. 2000 Dec 19;102(25):3137-47
references: 11120707
references: J Hypertens. 2001 May;19(5):843-50
references: 11393665
references: Circulation. 2011 Mar 1;123(8):933-44
references: 21262990
references: Eur Heart J. 2007 Jun;28(12):1462-536
references: 17562668
references: Lancet. 2002 Nov 2;360(9343):1347-60
references: 12423980
references: PLoS Med. 2006 Nov;3(11):e442
references: 17132052
references: Public Health Nutr. 2013 Feb;16(2):305-15
references: 22647342
references: Ann Pharmacother. 2008 May;42(5):633-9
references: 18413684
references: Lancet. 2004 Sep 11-17;364(9438):937-52
references: 15364185
references: Curr Diabetes Rev. 2012 Jan;8(1):48-54
references: 22414058
references: JAMA. 2010 Jan 20;303(3):235-41
references: 20071471
references: J Hypertens. 2007 Jul;25(7):1491-8
references: 17563573
references: JAMA. 2003 Jan 1;289(1):76-9
references: 12503980
references: Hypertension. 2004 Jan;43(1):10-7
references: 14638619
references: Int J Epidemiol. 2005 Apr;34(2):413-21
references: 15659467
references: J Am Coll Nutr. 1992 Jun;11 Suppl:8S-15S
references: 1619207
references: Diabet Med. 2012 Mar;29(3):385-92
references: 21913971
references: Diabetes Care. 2011 Jan;34 Suppl 1:S11-61
references: 21193625
references: Ann Ist Super Sanita. 2004;40(4):393-9
references: 15815105
references: Int J Obes Relat Metab Disord. 2001 Feb;25(2):185-90
references: 11410818
references: Blood Press Monit. 2003 Apr;8(2):91-5
references: 12819561
references: High Blood Press Cardiovasc Prev. 2008 Oct;15(4):283-310
references: 23355131
references: J Hypertens. 2012 Jun;30(6):1065-74
references: 22573073
references: Can J Cardiol. 2003 Oct;19(11):1249-59
references: 14571310
references: Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40
references: 20577089
references: Ther Adv Cardiovasc Dis. 2011 Feb;5(1):61-81
references: 21183531
references: J Hypertens. 2006 May;24(5):837-43
references: 16612244
references: Stroke. 2003 Oct;34(10):2349-54
references: 12958323
references: Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):443-50
references: 20031875
references: Diabetes Care. 2006 Jun;29(6):1263-8
references: 16732006
references: Acta Cardiol. 2009 Dec;64(6):771-8
references: 20128154
references: JAMA. 2010 May 26;303(20):2043-50
references: 20501926
references: Nutr Metab Cardiovasc Dis. 2003 Aug;13(4):211-7
references: 14650353
references: Circulation. 2003 May 6;107(17):2185-9
references: 12719276
references: JAMA. 2012 Mar 28;307(12):1273-83
references: 22427615
references: Eur Heart J. 1997 Aug;18(8):1231-48
references: 9458415
references: Cardiovasc J S Afr. 2005 Mar-Apr;16(2):112-7
references: 15915279
references: BMC Fam Pract. 2008 Sep 29;9:53
references: 18823526
references: Am J Med. 2004 Aug 15;117(4):219-27
references: 15308430
references: Eur Heart J. 2006 Jan;27(1):107-13
references: 16204263